Solve Therapeutics
United StatesEntry
2025
Hold
1yr
Status
Active
Who owns Solve Therapeutics?
Solve Therapeutics is an American Biotech company, currently owned by Abingworth since 2025 and General Atlantic.
Hand-verified · updated 2026-04-21
Open JSON · CC-BY
Most recent investor
AbingworthAbingworth Bioventures 8 · 2021 · Life Sciences VC
2 ownership periods · full history below
Key facts
HQUnited States
SectorBiotech
Ownership history
2 ownership periods
Active
AbingworthActive
2025 · present(1yr) · Abingworth Bioventures 8 · 2021 · Life Sciences VC
General AtlanticActive
present · General Atlantic core growth equity fund · 2013 · Growth
More from Abingworth Bioventures 8
Other portfolio companies in the same fund.
UK
More PE-backed in Biotech
Comparable biotech deals from other GPs.
Questions
Who owns Solve Therapeutics?
Solve Therapeutics is currently owned by Abingworth and General Atlantic, through Abingworth Bioventures 8, since 2025.
When did Abingworth and 1 other acquire Solve Therapeutics?
Abingworth and 1 other acquired Solve Therapeutics in 2025.
Who has owned Solve Therapeutics over time?
Solve Therapeutics has been through 2 private-equity ownership periods: Abingworth · via Abingworth Bioventures 8 · since 2025; General Atlantic · via General Atlantic core growth equity fund.
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue